Found 79 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

Program with 2 clinical trials
Program with 1 clinical trials
Hidradenitis Suppurativa Program
Program with 2 clinical trials
Diabetes Type 1 - ACT18368, DRI17476, EFC18241
Program with 2 clinical trials
An investigational medication is what is being studied to see if symptoms improve while taking it. It is not yet approved for general use by regulatory authorities. This study uses an investigational medication called Riliprubart. The investigational medicine is injected in a vein or under the skin, either at the …
18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication on adults with non-responsive celiac disease, where symptoms persist despite a gluten-free diet. This study aims to evaluate how the investigational medication affects changes in the intestinal lining compared to a placebo, focusing on the villous height to crypt depth ratio, …
18 years - 70 years
All genders
Phase 2
Interventional
This study investigates the efficacy and safety of an investigational medication in treating Systemic Lupus Erythematosus (SLE). Participants will be randomly assigned to one of two study arms: one receiving the investigational medication and the other receiving a placebo, which is an inactive substance that looks like the investigational medication …
18 years or above
All genders
Phase 3
Interventional
This study investigates the effectiveness and safety of an investigational medication for adults diagnosed with IgG4-related disease (IgG4-RD). The purpose of this study is to compare the investigational medication to a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine, over …
18 years or above
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication on individuals with warm autoimmune hemolytic anemia (wAIHA). The purpose is to compare the investigational medication with a placebo to determine its effectiveness and safety in improving hemoglobin levels in participants aged 18 and older with a confirmed diagnosis of primary …
18 years - 80 years
All genders
Phase 2
Interventional
This study investigates the effectiveness, safety, and tolerability of an investigational medication administered subcutaneously compared to a placebo in adults with high-risk asthma. This study is designed for adults between the ages of 18 and 80 who have asthma but are not eligible for biologic treatments.Participants in the study will …
18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the efficacy and safety of an investigational medication in adults with moderate-to-severe ulcerative colitis (UC). The purpose of this study is to evaluate how different doses of the investigational medication affect clinical remission in participants with moderate-to-severe UC.Participants will undergo procedures including a screening period and a …
1 - 10 of 79